Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 15,260 | 51,170 | 127,877 | 104,635 | -76,229 |
| Depreciation Amortization | 43,604 | 13,908 | 8,252 | 9,384 | 7,885 |
| Income taxes - deferred | -10,272 | 30,376 | -53,246 | -43,592 | 47,737 |
| Accounts receivable | -14,670 | -11,094 | -27,181 | -16,991 | 3,596 |
| Accounts payable and accrued liabilities | -1,319 | 18,903 | -2,203 | 165 | -7,851 |
| Other Working Capital | 10,301 | -60,567 | 15,963 | -12,384 | -3,398 |
| Other Operating Activity | 48,516 | 3,650 | 26,913 | 26,250 | 29,211 |
| Operating Cash Flow | $91,420 | $46,346 | $96,375 | $67,467 | $951 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,574 | -1,005 | -1,269 | -340 | -342 |
| Net Acquisitions | -542,579 | N/A | N/A | N/A | -37,168 |
| Purchase Of Investment | 1,125 | -67,854 | -41,083 | -128,240 | -133,700 |
| Sale Of Investment | 50,656 | 38,881 | 126,713 | 108,640 | 161,646 |
| Purchase Sale Intangibles | N/A | -36,678 | -7,000 | 263 | N/A |
| Other Investing Activity | 11 | -33,530 | -5,951 | 1,541 | -1,652 |
| Investing Cash Flow | $-504,361 | $-63,508 | $78,410 | $-18,399 | $-11,216 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 275,000 | 0 | N/A | N/A |
| Debt Repayment | N/A | -58,223 | 0 | N/A | N/A |
| Common Stock Issued | 263,812 | 61,360 | 6,725 | 3,361 | 1,804 |
| Common Stock Repurchased | N/A | -50,000 | 0 | N/A | N/A |
| Other Financing Activity | 7,675 | -7,216 | 9,393 | 0 | 0 |
| Financing Cash Flow | $271,487 | $220,921 | $16,118 | $3,361 | $1,804 |
| Exchange Rate Effect | -1,265 | 305 | -1,885 | 1,710 | -332 |
| Beginning Cash Position | 519,446 | 315,382 | 126,364 | 72,225 | 81,018 |
| End Cash Position | 376,727 | 519,446 | 315,382 | 126,364 | 72,225 |
| Net Cash Flow | $-142,719 | $204,064 | $189,018 | $54,139 | $-8,793 |
| Free Cash Flow | |||||
| Operating Cash Flow | 91,420 | 46,346 | 96,375 | 67,467 | 951 |
| Capital Expenditure | -13,574 | -1,005 | -1,269 | -340 | -342 |
| Free Cash Flow | 77,846 | 45,341 | 95,106 | 67,127 | 609 |